Bharat Biotech To Double Production Of Covaxin By June: Centre

The central government today said that the current production capacity of Covaxin will be doubled by May-June 2021. The production of Covaxin is expected to reach almost 10 crore doses per month by September 2021.

The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July – August 2021 i.e increasing the production from 1 crore vaccine doses in April, 2021 to 6-7 crore vaccine dose/month in July – August. It is expected to reach nearly 10 crore doses
per month by Sep 2021.

Few weeks back, inter-ministerial teams had visited the sites of main vaccine manufacturers in India to get their inputs on how production could be ramped up. In this period, there have been extensive reviews and feasibility studies on the plans being discussed with vaccine manufacturers. As a part this augmentation plan, capacities
of Bharat Biotech Limited, Hyderabad as well as other public sector manufactures are being upgraded with required infrastructure and technology. Financial support is being provided as grant from Government of India to the tune of approximately Rs 65 Crore to Bharat Biotech’s new Bangalore facility.